AAAAI |
American Academy of Allergy, Asthma and Immunology |
AGATE |
Working Group on Anaphylaxis – Training and Education |
ASA |
Acetylsalicylic acid |
BAT |
Basophil activation test |
OD |
Occupational disease |
CCD |
Cross-reactive carbohydrate determinants, cross-reactive carbohydrate side chains |
CSACI |
Canadian Society of Allergy and Clinical Immunology |
DBPCFC |
Double-blind placebo-controlled food challenge |
DGES |
Study on the health of adults in Germany |
DELBI |
German instrument for methodological guideline evaluation |
EAACI |
European Academy of Allergy and Clinical Immunology |
EGID |
Eosinophilic gastrointestinal disorders, eosinophil-associated diseases of the gastrointestinal tract |
FDA |
Food and drug administration |
FPIES |
Food protein-induced enterocolitis syndrome, food protein-induced enterocolitis syndrome |
GIT |
Gastrointestinal tract |
HMO |
Human milk oligosaccharides |
HMW |
High molecular weight |
IgE |
Immunoglobulin E |
IgG |
Immunoglobulin G |
GR |
Gastroesophageal reflux |
CI |
Confidence interval |
CU |
Contact urticaria |
LCPUFA |
Long-chain polyunsaturated fatty acids |
LY |
Life year |
LMIV |
Food Information Regulation |
LoQ |
Limit of quantitation |
LTP |
Lipid transfer protein |
NPV |
Negative predictive value |
NSAID |
Non-steroidal anti-inflammatory drug |
nsLTP |
Non-specific lipid transfer protein |
OAS |
Oral allergy syndrome |
OD |
Occupational disease |
OIT |
Oral immunotherapy |
PCD |
Protein contact dermatitis |
PPI |
Proton pump inhibitor |
PPV |
Positive predictive value |
PR-10 |
Pathogenesis-related protein family 10 |
RWC |
Reduction in earning capacity |
SCIT |
Subcutaneous immunotherapy |
SIT |
Specific immunotherapy |
SLIT |
Sublingual immunotherapy |
WDEIA |
Wheat-dependent exercise-induced anaphylaxis |